Malignant Hematology Team

Physicians looking to refer a patient to experienced malignant hematology specialists can consider the many advantages of receiving treatment at Moffitt Cancer Center. Led by Jeffrey Lancet, MD, the team that makes up our Malignant Hematology Program focuses exclusively on the diagnosis and treatment of different blood cancers and autoimmune disorders. Our program’s survival rates are better than the national averages, and as a high-volume cancer center, our malignant hematology specialists have a unique level of experience treating patients with conditions like:

• Leukemia
• Lymphoma
• Myelodysplastic syndromes (MDS)
• Myeloproliferative syndromes
• Multiple myeloma
• Aplastic anemia
• Other hematological malignancies

Individualized treatment plans from our malignant hematology specialists

When a patient is referred to Moffitt, we will provide a complete diagnostic workup, including staging and pathology services, to get a full picture of the patient’s condition. Then, our malignant hematology specialists – including medical oncologists, hematopathologists and others – will review his or her case to ensure we provide an individualized treatment plan that will give the patient the best chance at reaching a favorable outcome and an improved quality of life. Depending on the specifics of a patient’s malignancy, a treatment plan may consist of a combination of the following:

• Chemotherapy
• Immunotherapy
• Bone marrow transplantation
• Anti-angiogenesis therapy
• Promising clinical trials for eligible patients

At Moffitt, our focus extends beyond clinical treatment. We also tend to our patients’ quality of life. That’s why our patients have access to pain management specialists, dietitians, counselors and other supportive care professionals to help them cope with the challenges of undergoing cancer treatment.

Malignant Hematology Specialists Team

Medical Oncology

Hugo Fernandez, MD

Department Chair

Sub Specialty:
Hematology Medical Oncology

Program:
Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Julio Chavez, MD, MS

Sub Specialty:
Medical Oncology

Program:
Malignant Hematology

Sameh Gaballa, MD

Program:
Malignant Hematology

Eric Padron, MD

Sub Specialty:
Medical Oncology Hematology

Program:
Malignant Hematology

Ken Shain, MD, PhD

Sub Specialty:
Medical Oncology

Program:
Malignant Hematology

Kendra Sweet, MD

Sub Specialty:
Medical Oncology

Program:
Malignant Hematology

Hematology/Oncology

Rachid Baz, MD

Sub Specialty:
Hematology Medical Oncology

Program:
Malignant Hematology

Celeste Bello, MD

Sub Specialty:
Medical Oncology Hematology

Program:
Malignant Hematology

Brandon Blue, MD

Program:
Malignant Hematology

Onyee Chan, MD

Program:
Malignant Hematology

Yehuda Deutsch, MD

Sub Specialty:
Hematology Medical Oncology

Program:
Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Ning Dong, MD, MS

Program:
Malignant Hematology

Ariel Grajales-Cruz, MD

Program:
Malignant Hematology

Leidy Isenalumhe, MD, MS

Sub Specialty:
Hematology Pediatric Hematology-Oncology Medical Oncology

Program:
Malignant Hematology

Rami Komrokji, MD

Sub Specialty:
Hematology Medical Oncology

Program:
Malignant Hematology

Timothy Kubal, MD, MBA

Program:
Malignant Hematology

Andrew Kuykendall, MD

Program:
Malignant Hematology

Jenn Logue, MD

Program:
Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Nina Nguyen, MD

Program:
Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Claudia Paba Prada, MD

Program:
Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Javier Pinilla, MD, PhD

Sub Specialty:
Medical Oncology Hematology

Program:
Malignant Hematology

Hayder Saeed, MD

Program:
Malignant Hematology

David Sallman, MD

Sub Specialty:
Hematology Medical Oncology

Program:
Malignant Hematology

Jose Sandoval Sus, MD

Sub Specialty:
Hematology Medical Oncology

Program:
Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Bijal Shah, MD, MS

Sub Specialty:
Hematology Medical Oncology

Program:
Malignant Hematology

Carlos Silva Rondon, MD

Program:
Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Lubomir Sokol, MD, PhD

Sub Specialty:
Medical Oncology Hematology

Program:
Malignant Hematology

Fernando Vargas, MD

Program:
Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Alison Walker, MD, MPH, MBA

Program:
Malignant Hematology

Zoey Xie, MD, MS

Program:
Malignant Hematology

Seongseok Yun, MD, PhD

Program:
Malignant Hematology

Hematology

Jeffrey Lancet, MD

Department Chair

Sub Specialty:
Hematology Medical Oncology

Program:
Malignant Hematology

Moffitt welcomes referrals for patients with a confirmed diagnosis as well as those with suspected hematologic conditions. To refer a patient to the malignant hematology specialists at Moffitt, health care providers can complete our online form or contact a physician liaison for assistance or support. We aim to make referral times as short as possible.